St. Louis, Missouri – June 5, 2015 — BacterioScan Inc. named as a Red Herring Top 100 North America award winner in recognition of the Company’s vision, drive and innovations in rapid laboratory diagnostics.
Red Herring Top 100 America selects outstanding entrepreneurs and promising companies from approximately 1,200 privately financed companies each year in the US and Canada. “In 2015, selecting the top achievers was by no means a small feat,” said Alex Vieux, publisher and CEO of Red Herring. “In fact, we had the toughest time in years because so many entrepreneurs had crossed significant milestones so early. But after much thought, rigorous contemplation and discussion, we narrowed our list down from hundreds of candidates from across North America to the North America winners. We believe BacterioScan embodies the vision, drive and innovation that define a successful entrepreneurial venture. BacterioScan should be proud of its accomplishment, as the competition was very strong.”
“BacterioScan is honored to be named as a Red Herring Top 100 winner”, said Dana Marshall, BacterioScan’s President and CEO. “Our in vitro laboratory diagnostics platform will shorten antibiotic drug development with our two-hour antibiotic susceptibility platform (AST) time and the way we identify and treat bacterial infections. BacterioScan’s technology platform can provide researchers and clinicians with patient-specific guidance on the most rapid and cost-effective treatment plan for bacterial infections. This phenotypic approach to early detection and targeted intervention support the global need for optimal, informed antibiotics usage and to control and monitor antimicrobial resistance.
BacterioScan’s first medical device product is a compact, simple, and low-cost system for rapid detection of Urinary Tract Infection (UTI) for use in clinical microbiology labs. BacterioScan is a privately held global corporation with headquarters in St Louis, Missouri.
About BacterioScan Inc.
BacterioScan Inc. (www.bacterioscan.com) is an in-vitro diagnostics (IVD) company focused on the rapid detection and real-time quantification of bacteria in fluid using optical measurements. BacterioScan’s instruments can rapidly detect infection, determine if it is resistant to a range of antibiotics, and provide clinicians with patient-specific guidance on the most rapid and cost-effective treatment plan. BacterioScan’s first medical device product is a compact, simple, and low-cost system for rapid detection of Urinary Tract Infection (UTI) for use in clinical microbiology labs. BacterioScan is a privately held global corporation, with headquarters in St Louis, Missouri.
Help employers find you! Check out all the jobs and post your resume.
